Ror2 as a therapeutic target in cancer
Zufan Debebe1, W Kimryn Rathmell2
1Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
Pharmacology & Therapeutics
|January 24, 2015
Summary
The Ror2 receptor, crucial in development, is implicated in various cancers, promoting aggressive disease. Targeting Ror2 offers therapeutic potential, even through non-kinase pathways.
Area of Science:
- Molecular Biology
- Oncology
- Developmental Biology
Background:
- Ror2 is a Wnt signaling receptor vital for limb development.
- Its role in adult tissues was previously unknown.
- Ror2 mediates both canonical and non-canonical Wnt pathways.
Purpose of the Study:
- To explore the role of Ror2 in cancer.
- To assess Ror2 as a therapeutic target.
Main Methods:
- Expression analysis in various cancer types.
- Correlation of Ror2 expression with disease aggressiveness.
Main Results:
- Ror2 is highly expressed in osteosarcoma, renal cell carcinoma, melanoma, colon cancer, head and neck squamous cell carcinoma, and breast cancer.
- Ror2 expression correlates with aggressive disease states in these cancers.
- Ror2's cell surface localization and association with high-risk diseases make it a potential therapeutic target.
Conclusions:
- Ror2 plays a significant role in multiple cancer types, associated with poor prognosis.
- Targeting Ror2 presents a promising therapeutic strategy.
- The discovery of Ror2's non-kinase activities opens new avenues for therapeutic development.
Related Concept Videos
Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies
1.8K
1.8K
Cancer Therapies
10.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.9K
Cancer Therapies
3.0K
3.0K
Treatment Resistent Cancers
1.5K
1.5K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K


